Jochen U.
- Country
- Germany
- Department
- Department of Dermatology, Venereology and Allergology
Research Overview
- Evaluation of Belvarafenib Monotherapy and Combination Therapy with Cobimetinib and Nivolumab in NRAS-Mutant Advanced Cutaneous Melanoma Patients
- A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab with Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants with High-risk Stage II-IV Melanoma (KEYVIBE-010)
- Adjuvant Therapy with Pembrolizumab versus Placebo in Resected Highrisk Stage II Melanoma: A Randomized, Double-blind Phase 3 Study (KEYNOTE 716)
Data & Insights
Has run more than one trial at 117 of 229 partner sites.
Specializations
Melanoma Treatment
This investigator specializes in the treatment of unresectable and metastatic melanoma, with particular emphasis on advanced therapeutic approaches for patients with limited treatment options.
- Advanced Cutaneous Melanoma
- NRAS Mutant Melanoma
- Metastatic Disease Management
The investigator focuses on developing treatment strategies for specific melanoma subtypes, including NRAS mutant cutaneous melanoma.
Immunotherapy Innovation
The investigator works with novel immunotherapeutic approaches, including monoclonal antibody treatments and their combinations in melanoma therapy.
- Combination Immunotherapy
- Targeted Antibody Development
- Immune Response Modulation
Research interests include the application of Fc-engineered antibodies and their interaction with immune checkpoint inhibitors.
Therapeutic Development
The investigator explores innovative treatment combinations, including targeted therapy approaches for melanoma patients.
- Novel Drug Combinations
- Treatment Optimization
- Advanced Therapeutic Strategies
Focus areas include the development of targeted therapeutic combinations for specific melanoma mutations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.